Miglustat does not appear to be associated with aspartate aminotransferase (AST) and ALT elevations in humans with Gaucher disease, Niemann-Pick disease (NPC), and Fabry disease (Zavesca SmPC), at doses of 100 mg TID or less [40]. The gene discussed is GPT; the disease is Fabry disease.